A prescription frame is a small product with a long compliance trail. Teams focus on hinge feel, rim shape, plating color, and sample appearance. Market access may appear only when cartons are packed and someone asks for a declaration or valid report.
Compliance belongs in the specification before tooling.
A prescription frame is an unglazed frame intended to hold corrective lenses. The category includes full rim, semi-rimless, rimless, folding, 3D printed, and natural material constructions.
Plano sunglasses, protective eyewear, prescription lenses, and ready made readers can follow different routes. Even a clip on sun lens may change the scope. Define intended use before asking which standard applies.
For international sourcing, ISO 12870 is the practical baseline. It gives the buyer, factory, and laboratory a shared reference. It does not replace national law.
ISO 12870:2024 specifies requirements and test methods for unglazed frames intended for prescription lenses. Its scope includes mass produced full rim, semi-rimless, rimless, folding, additively manufactured, and natural material frames.
The key issue is whether the tested sample represents the order. Thin acetate around the eyewire, a soldered bridge, or plating near a flex point can change performance. A frame may look perfect and still behave badly during glazing.
“Test to ISO 12870” is incomplete. Standards are revised, while laboratories and suppliers may keep using older templates.
The purchase order should state:
A plated frame and an uncoated version are not automatically the same test family.
The U.S. route is often called easy because ordinary spectacle frames are generally exempt from premarket notification. Easy is the wrong word. The frame still sits inside the FDA medical device system.
Yes. Under 21 CFR 886.5842, a spectacle frame is a Class I device intended to hold prescription lenses. It is generally exempt from 510(k), subject to the regulation’s limitations.
The useful sourcing question is: who is the legal manufacturer? The factory, brand owner, and importer may carry different responsibilities.
Requirements may include establishment registration, device listing, a U.S. Agent for foreign manufacturers, labeling controls, complaint handling, reporting, and quality system compliance.
The Quality Management System Regulation became effective on February 2, 2026. It revised 21 CFR Part 820 and incorporates ISO 13485:2016 by reference, with added FDA requirements.
A certificate on the wall is less revealing than change control. When a hinge supplier changes, the bill of materials, inspection criteria, and test evidence should move with it.
The impact resistance requirement in 21 CFR 801.410 applies to spectacle lenses and sunglasses, not an empty optical frame. FDA states that lenses sold in the U.S. must meet the impact resistant lens regulation and carry compliance certification.
For complete eyewear, frame and lens compliance remain connected. A strong frame does not compensate for an uncertified lens.
In the EU, corrective spectacle frames are Class I medical devices. Intended purpose, classification, technical documentation, labeling, traceability, and post market controls must point to the same product.
Ordinary non-sterile, non-measuring Class I frames generally use manufacturer self assessment under the Medical Device Regulation. The manufacturer prepares technical documentation, issues the EU Declaration of Conformity, and applies the CE mark. A notified body is normally not involved.
CE marking is not a laboratory certificate. It is the manufacturer’s declaration, supported by the technical file.
A manufacturer outside the EU needs an EU Authorized Representative. The importer must verify key compliance elements before placing the frame on the market. Identification, labeling, complaint flow, traceability, and post market surveillance should be assigned in writing.
UDI also needs attention. EU guidance revised in March 2026 covers Master UDI-DI for spectacle frames. The rules apply from November 1, 2028, while EUDAMED arrangements still need monitoring.
Old label artwork is not a compliance strategy.
No. An ISO 12870 report can support the technical file, but it does not replace classification, risk management, labeling review, post market planning, or the Declaration of Conformity.
Report scope matters. The model name on page one is less important than the tested construction, material, finish, and size range. Evidence that cannot be linked to the current bill of materials is weak.
The markets share engineering concerns, but their paperwork is not interchangeable.
| Compliance topic | Stati Uniti | European Union |
| Regulatory status | FDA Class I device | MDR Class I device |
| Premarket route | Generally 510(k)-exempt | Usually self assessment |
| Core records | Registration, listing, U.S. Agent where applicable | Technical file, Declaration, CE mark, EU representative |
| Quality controls | FDA QMSR | MDR quality management processes |
| Traceability | FDA device controls | Operator, UDI, and EUDAMED controls |
“The model passed EU testing, so the U.S. is covered” is an incomplete answer.
The request should match the product and market. More files are not necessarily better. Relevant files are.
A useful factory check: choose one carton and trace it to the material lot, inspection record, and approved sample. Conflicting spreadsheets mean the compliance file is not mature.
A reliable specification names the market, intended use, standard edition, materials, finish, critical dimensions, inspection points, required documents, and change control triggers.
For an OEM/ODM program, SUSON can review these inputs before sampling and align development, testing, production control, and compliance records around the same product definition. That is safer than testing a “representative model” after packing.
Domanda: Is ISO 12870 mandatory for every prescription frame?
Not automatically. It may become required through national adoption, a conformity strategy, or the purchase contract.
Domanda: Does a 510(k)-exempt frame still need FDA controls?
Yes. Exemption from 510(k) does not remove other FDA duties that may apply.
Domanda: Can one report cover several colors and sizes?
Sometimes. The grouping needs technical justification because material, coating, geometry, hinge design, and size can affect performance.
Domanda: Does CE marking prove that every batch was inspected?
No. Batch inspection and traceability remain production control responsibilities.
